Physician profile
Andy Nguyen
NPI 1033362694
$573.93
in general payments reported to CMS, 2019-2025
16 companies · $85.55 in 2025
The $85.55 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $291 · 2020: $69.60 · 2021: $28.90 · 2023: $78.95 · 2024: $20.08 · 2025: $85.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $184.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $151.73 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $78.95 | 2023 | |
| Kite Pharma, INC. | $54.12 | 2019-2020 | |
| Seagen INC. | $30.94 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.95 | 2019 | |
| Jazz Pharmaceuticals INC. | $28.90 | 2021 | |
| Legend Biotech USA INC. | $25.70 | 2025 | Carvykti |
| Novo Nordisk INC | $24.96 | 2025 | Ozempic, Rybelsus |
| Pfizer INC. | $24.22 | 2019 | |
| Amgen INC. | $20.09 | 2020 | |
| Gilead Sciences, INC. | $20.08 | 2024 | |
| Adaptive Biotechnologies Corporation | $19.50 | 2025 | Clonoseq |
| Abbvie INC. | $18.30 | 2019 | |
| Grifols USA, LLC | $16.90 | 2019 | |
| Boston Scientific Corporation | $15.39 | 2025 | General - Pain Management |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Servier Pharmaceuticals LLC | $15.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andy Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.